Login Register Cart 0
Generic placeholder image

Current Diabetes Reviews

Editor-in-Chief

ISSN (Print): 1573-3998
ISSN (Online): 1875-6417

Back
Journal Home About Journal Editorial Board Journal Insight Current Issue Volumes/Issues
Subscribe
Mini-Review Article

Conceptual Overview of Prevalence of Prediabetes

In Press, (this is not the final "Version of Record"). Available online 03 April, 2024
Author(s): Monika, Pragi Arora*, Varun Kumar and Pankaj Popli
Published on: 03 April, 2024

Article ID: e030424228558

DOI: 10.2174/0115733998285294240307052909

Price: $95

Abstract

Prediabetes increases the risk of type 2 diabetes, metabolic syndrome, chronic renal disease, and cardiovascular disease in a person. In current practice, five alternative definitions of prediabetes are utilized, each based on different HbA1C, fasting glucose, and 2-hour glucose cut points. Prediabetes is a common condition that occurs between normal glycemia and diabetes. It is more common in elderly and obese people. The prevalence of prediabetes and diabetes can be influenced by a variety of individual, family, and societal variables. Additionally, as diabetes is the primary contributor to non-communicable diseases (NCD), it is crucial to identify the key temporal variables for diabetes early diagnosis. In turn, effective prediabetes and diabetes awareness, control, and preventive programs may be created by policymakers and public health professionals worldwide. Popular pathogenic pathways in prediabetes include insulin resistance, inflammation, and sensitivity to insulin. HBA1C, OGTT, and FPG are discussed as the diagnostic criteria in order of frequency. The most commonly researched therapies in the realm of prediabetes are metformin, exercise, and physical activity. Physiological markers including BMI, blood pressure, and waist circumference prompted relatively significant concern. Despite declining trends, the study demonstrates that prediabetes and diabetes are widely prevalent. In order to prevent non-communicable illnesses, the research suggests encouraging healthy lifestyles and regular screenings.

[1]
American Diabetes Association. Classification and diagnosis of diabetes: Standards of medical care in diabetes-2020. Diabetes Care 2020; 43(S1): S14-31.
[PMID: 31862745]
[2]
Tabák AG, Herder C, Rathmann W, Brunner EJ, Kivimäki M. Prediabetes: A high-risk state for diabetes development. Lancet 2012; 379(9833): 2279-90.
[http://dx.doi.org/10.1016/S0140-6736(12)60283-9] [PMID: 22683128]
[3]
Vas PRJ, Alberti KG, Edmonds ME. Prediabetes: Moving away from a glucocentric definition. Lancet Diabetes Endocrinol 2017; 5(11): 848-9.
[http://dx.doi.org/10.1016/S2213-8587(17)30234-6] [PMID: 28781065]
[4]
WHO, International Diabetes Foundation. Definition and diagnosis of diabetes mellitus and intermediate hyperglycaemia: report of a WHO/IDF consultation. Geneva: World Health Organization 2006.
[5]
Goldenberg R, Punthakee Z. Definition, classification and diagnosis of diabetes, prediabetes and metabolic syndrome. Can J Diabetes 2013; 37(S1): S8-S11.
[http://dx.doi.org/10.1016/j.jcjd.2013.01.011] [PMID: 24070969]
[6]
American Diabetes Association. Classification and diagnosis of diabetes: Standards of medical care in diabetes-2018. Diabetes Care 2018; 41(S1): S13-27.
[http://dx.doi.org/10.2337/dc18-S002] [PMID: 29222373]
[7]
Centers for Disease Control and Prevention. National diabetes fact sheet: national estimates and general information on diabetes and prediabetes in the United States. Atlanta, GA: US Department of Health and Human Services, Centers for Disease Control and Prevention 2011.
[8]
American Diabetes Association Diagnosis and classification of diabetes mellitus. Diabetes Care 2011; 34(1): S62-9.
[9]
Prevention or delay of type 2 diabetes: Standards of Medical Care in Diabetes–2020. Diabetes Care 2020; 43(1): S32-6.
[PMID: 31862746]
[10]
Wagner A. Prediabetes An Emerging Epidemic. Ann Arbor, MI: University of Michigan Health System 2015; pp. 1-10.
[11]
Makaroff LE. The need for international consensus on prediabetes. Lancet Diabetes Endocrinol 2017; 5(1): 5-7.
[http://dx.doi.org/10.1016/S2213-8587(16)30328-X] [PMID: 27863980]
[12]
Nathan DM, Davidson MB, DeFronzo RA, et al. Impaired fasting glucose and impaired glucose tolerance: Implications for care. Diabetes Care 2007; 30(3): 753-9.
[http://dx.doi.org/10.2337/dc07-9920] [PMID: 17327355]
[13]
International Diabetes Federation. IDF Diabetes Atlas. (8th ed.), Brussels, Belgium: International Diabetes Federation 2017.
[14]
Wild S, Roglic G, Green A, Sicree R, King H. Global prevalence of diabetes: Estimates for the year 2000 and projections for 2030. Diabetes Care 2004; 27(5): 1047-53.
[http://dx.doi.org/10.2337/diacare.27.5.1047] [PMID: 15111519]
[15]
Lee CM, Colagiuri S. Diagnostic criteria and classification. In: Diabetes Epidemiology, Genetics, Pathogenesis, Diagnosis, Prevention, and Treatment. Springer International Publishing 2018; pp. 23-9.
[http://dx.doi.org/10.1007/978-3-319-45015-5_3]
[16]
American Diabetes Association. Classification and diagnosis of diabetes.Sec. In standards of medical care in diabetes 2017. Diabetes Care 2017; 40(1): S11-24.
[17]
Bullard KM, Saydah SH, Imperatore G, et al. Secular changes in U.S. Prediabetes prevalence defined by hemoglobin A1c and fasting plasma glucose: National health and nutrition examination surveys, 1999-2010. Diabetes Care 2013; 36(8): 2286-93.
[http://dx.doi.org/10.2337/dc12-2563] [PMID: 23603918]
[18]
Gerstein HC, Santaguida P, Raina P, et al. Annual incidence and relative risk of diabetes in people with various categories of dysglycemia: A systematic overview and meta-analysis of prospective studies. Diabetes Res Clin Pract 2007; 78(3): 305-12.
[http://dx.doi.org/10.1016/j.diabres.2007.05.004] [PMID: 17601626]
[19]
Kowall B, Rathmann W, Heier M, et al. Categories of glucose tolerance and continuous glycemic measures and mortality. Eur J Epidemiol 2011; 26(8): 637-45.
[http://dx.doi.org/10.1007/s10654-011-9609-y] [PMID: 21785986]
[20]
Herman WH, Pan Q, Edelstein SL, et al. Impact of lifestyle and metformin interventions on the risk of progression to diabetes and regression to normal glucose regulation in overweight or obese people with impaired glucose regulation. Diabetes Care 2017; 40(12): 1668-77.
[http://dx.doi.org/10.2337/dc17-1116] [PMID: 29021207]
[21]
Knowler WC, Connor BE, Fowler SE, et al. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med 2002; 346(6): 393-403.
[http://dx.doi.org/10.1056/NEJMoa012512] [PMID: 11832527]
[22]
Definition and diagnosis of diabetes mellitus and intermediate hyperglycemia: report of a WHO/IDF consultation. Geneva: World Health Organization 2006; pp. 1-50.
[23]
Wexlar DJ, Nathan DM, Rubinow K. Management of persistence hyperglycemia in Diabetes Mellitus. 2023. Available from: https://www.uptodate.com/contents/management-of-persistenthyperglycemia-in-type-2-diabetes-mellitus
[24]
Janghorbani M, Amini M. Normal fasting plasma glucose and risk of prediabetes and type 2 diabetes: the Isfahan Diabetes Prevention Study. Rev Diabet Stud 2011; 8(4): 490-8.
[http://dx.doi.org/10.1900/RDS.2011.8.490] [PMID: 22580730]
[25]
Karve A, Hayward RA. Prevalence, diagnosis, and treatment of impaired fasting glucose and impaired glucose tolerance in nondiabetic U.S. adults. Diabetes Care 2010; 33(11): 2355-9.
[http://dx.doi.org/10.2337/dc09-1957] [PMID: 20724649]
[26]
Yip W, Sequeira I, Plank L, Poppitt S. Prevalence of pre-diabetes across ethnicities: A review of impaired fasting glucose (IFG) and impaired glucose tolerance (IGT) for classification of Dysglycaemia. Nutrients 2017; 9(11): 1273.
[http://dx.doi.org/10.3390/nu9111273] [PMID: 29165385]
[27]
Blum J, Aeschbacher S, Schoen T, et al. Prevalence of prediabetes according to hemoglobin A1c versus fasting plasma glucose criteria in healthy adults. Acta Diabetol 2015; 52(3): 631-2.
[http://dx.doi.org/10.1007/s00592-014-0659-y] [PMID: 25344149]
[28]
Treatment of type 2 diabetes mellitus in the older patient. 2023. Available from: https://www.uptodate.com/contents/treatment-of-type-2-diabetes-mellitus-in-the-older-patient
[29]
Pouya S, Inga P. Global and regional diabetes prevalence estimates for 2019 and projections for 2023 and 2045: Results from International Diabetes and Federation Diabetes Atlas. Diabetes Resh. Clin Pract 2019; 9(10)
[30]
Farmaki AE, Garfield V, Eastwood SV, et al. Type 2 diabetes risks and determinants in second-generation migrants and mixed ethnicity people of South Asian and African Caribbean descent in the UK. Diabetologia 2022; 65(1): 113-27.
[http://dx.doi.org/10.1007/s00125-021-05580-7] [PMID: 34668055]
[31]
Sun H, Saeedi P, Karuranga S, et al. IDF diabetes atlas: Global, regional and country-level diabetes prevalence estimates for 2021 and projections for 2045. Diabetes Res Clin Pract 2022; 183: 109119.
[http://dx.doi.org/10.1016/j.diabres.2021.109119] [PMID: 34879977]
[32]
United Nations. 2018 Revision of world urbanization prospects. 2018. Available from: https://www.un.org/en/desa/2018-revision-world-urbanization-prospects
[33]
Rooney MR, Fang M, Ogurtsova K, et al. Global prevalence of prediabetes. Diabetes Care 2023; 46(7): 1388-94.
[http://dx.doi.org/10.2337/dc22-2376] [PMID: 37196350]
[34]
Prashant M, Sravya L, Vaitheeswaran K. Prevalence, awareness, treatment and control of diabetes. Frontiers 2022; 10.
[35]
What is prediabetes? 2020. Available from: https://www.healthline.com/health/type-2-diabetes/what-is-prediabetes#symptoms
[36]
Garber AJ. Obesity and type 2 diabetes: Which patients are at risk? Diabetes Obes Metab 2012; 14(5): 399-408.
[http://dx.doi.org/10.1111/j.1463-1326.2011.01536.x] [PMID: 22074144]
[37]
Barbarroja N, Pedrera LR, Mayas MD, et al. The obese healthy paradox: Is inflammation the answer? Biochem J 2010; 430(1): 141-9.
[http://dx.doi.org/10.1042/BJ20100285] [PMID: 20522023]
[38]
Wild SH, Byrne CD. Risk factors for diabetes and coronary heart disease. BMJ 2006; 333(7576): 1009-11.
[http://dx.doi.org/10.1136/bmj.39024.568738.43] [PMID: 17095784]
[39]
Ainsworth B, Haskell WL, Leon AS, et al. Compendium of physical activities: Classification of energy costs of human physical activities. Med Sci Sports Exerc 1993; 25(1): 71-80.
[http://dx.doi.org/10.1249/00005768-199301000-00011] [PMID: 8292105]
[40]
Wilmot EG, Edwardson CL, Achana FA, et al. Sedentary time in adults and the association with diabetes, cardiovascular disease and death: Systematic review and meta-analysis. Diabetologia 2012; 55(11): 2895-905.
[http://dx.doi.org/10.1007/s00125-012-2677-z] [PMID: 22890825]
[41]
Centers for Disease Control and Prevention. National diabetes statistics report. 2017. Available from: https://www.cdc.gov/diabetes/data/statistics-report/index.html
[42]
Ali A. Health Survey for England Cardiovascular Disease and Risk Factors in Adults. London, UK: National Centre for Social Research 2008.
[43]
Suastika K, Dwipayana P, Saraswati RIM, et al. Relationship between age and metabolic disorders in the population of Bali. JCGG 2011; 2(2): 47-52.
[http://dx.doi.org/10.1016/j.jcgg.2011.03.001]
[44]
Nam Han C, Joses K, Jean CM. Diabetes Atlas. (8th ed.), Diabetes by Region 2017.
[45]
Kautzky-Willer A, Leutner M, Harreiter J. Sex differences in type 2 diabetes. Diabetologia 2023; 66(6): 986-1002.
[http://dx.doi.org/10.1007/s00125-023-05891-x] [PMID: 36897358]
[46]
Garawi F, Devries K, Thorogood N, Uauy R. Global differences between women and men in the prevalence of obesity: Is there an association with gender inequality? Eur J Clin Nutr 2014; 68(10): 1101-6.
[http://dx.doi.org/10.1038/ejcn.2014.86] [PMID: 24918120]
[47]
Willer KA, Harreiter J, Pacini G. Sex and gender differences in risk, pathophysiology and complications of type 2 diabetes mellitus. Endocr Rev 2016; 37(3): 278-316.
[http://dx.doi.org/10.1210/er.2015-1137] [PMID: 27159875]
[48]
Adam ZR, Sara DN. Sex- biased gene regulation varies across human populations as a result of adaptive evolution. BioRxiv 2023.
[49]
Gabory A, Attig L, Junien C. Developmental programming and epigenetics. Am J Clin Nutr 2011; 94(S6): S1943-52.
[http://dx.doi.org/10.3945/ajcn.110.000927] [PMID: 22049164]
[50]
Petrie JR, Guzik TJ, Touyz RM. Diabetes, hypertension, and cardiovascular disease: Clinical insights and vascular mechanisms. Can J Cardiol 2018; 34(5): 575-84.
[http://dx.doi.org/10.1016/j.cjca.2017.12.005] [PMID: 29459239]
[51]
Yonas A, Yitayeh B. Hypertension and its associated factors among type 2 diabtes mellitus patients at debre tabor general hospital. north-west ethiopia. Dovepress 2020; 20(13): 1621-31.
[52]
Fowler MJ. Microvascular and macrovascular complications of diabetes. Clin Diabetes 2008; 26(2): 77-82.
[http://dx.doi.org/10.2337/diaclin.26.2.77]
[53]
Cheung BMY, Li C. Diabetes and hypertension: Is there a common metabolic pathway? Curr Atheroscler Rep 2012; 14(2): 160-6.
[http://dx.doi.org/10.1007/s11883-012-0227-2] [PMID: 22281657]
[54]
Cheung BMY. The hypertension-diabetes continuum. J Cardiovasc Pharmacol 2010; 55(4): 333-9.
[http://dx.doi.org/10.1097/FJC.0b013e3181d26430] [PMID: 20422737]
[55]
Carlsson S, Midthjell K, Grill V. Smoking is associated with an increased risk of type 2 diabetes but a decreased risk of autoimmune dia-betes in adults: An 11-year follow-up of incidence of diabetes in the Nord-Trøndelag study. Diabetologia 2004; 47(11): 1953-6.
[http://dx.doi.org/10.1007/s00125-004-1554-9] [PMID: 15558231]
[56]
Willi C, Bodenmann P, Ghali WA, Faris PD, Cornuz J. Active smoking and the risk of type 2 diabetes: A systematic review and meta-analysis. JAMA 2007; 298(22): 2654-64.
[http://dx.doi.org/10.1001/jama.298.22.2654] [PMID: 18073361]
[57]
Madsbad S, McNair P, Christensen MS, et al. Influence of smoking on insulin requirement and metbolic status in diabetes mellitus. Diabetes Care 1980; 3(1): 41-3.
[http://dx.doi.org/10.2337/diacare.3.1.41] [PMID: 6996967]
[58]
Chen Z, Liu X, Kenny PJ. Central and peripheral actions of nicotine that influence blood glucose homeostasis and the development of diabetes. Pharmacol Res 2023; 194: 106860.
[http://dx.doi.org/10.1016/j.phrs.2023.106860] [PMID: 37482325]
[59]
Epifano L, Di Vincenzo A, Fanelli C, et al. Effect of cigarette smoking and of a transdermal nicotine delivery system on glucoregulation in type 2 diabetes mellitus. Eur J Clin Pharmacol 1992; 43(3): 257-63.
[http://dx.doi.org/10.1007/BF02333019] [PMID: 1425888]
[60]
Frati AC, Iniestra F, Ariza CR. Acute effect of cigarette smoking on glucose tolerance and other cardiovascular risk factors. Diabetes Care 1996; 19(2): 112-8.
[http://dx.doi.org/10.2337/diacare.19.2.112] [PMID: 8718429]
[61]
Mills JD, Grant PJ. Insulin resistance, haemostatic factors and cardiovascular risk. Br J Diabetes Vasc Dis 2002; 2(1): 19-26.
[http://dx.doi.org/10.1177/14746514020020011301]
[62]
Monsalve FA, Pyarasani RD, Lopez DF, Carrasco MR. Peroxisome proliferator-activated receptor targets for the treatment of metabolic diseases. Mediators Inflamm 2013; 2013: 1-18.
[http://dx.doi.org/10.1155/2013/549627] [PMID: 23781121]
[63]
Maddatu J, Baucum AE, Molina EC. Smoking and the risk of type 2 diabetes. Transl Res 2017; 184: 101-7.
[http://dx.doi.org/10.1016/j.trsl.2017.02.004] [PMID: 28336465]
[64]
Tuovinen EL, Saarni SE, Männistö S, et al. Smoking status and abdominal obesity among normal- And overweight/obese adults: Population-based FINRISK study. Prev Med Rep 2016; 4: 324-30.
[http://dx.doi.org/10.1016/j.pmedr.2016.07.003] [PMID: 27486563]
[65]
Kao WHL, Puddey IB, Boland LL, Watson RL, Brancati FL. Alcohol consumption and the risk of type 2 diabetes mellitus: Atherosclerosis risk in communities study. Am J Epidemiol 2001; 154(8): 748-57.
[http://dx.doi.org/10.1093/aje/154.8.748] [PMID: 11590088]
[66]
Knott C, Bell S, Britton A. Alcohol consumption and the risk of type 2 diabetes: A systematic review and dose-response meta-analysis of more than 1.9 million individuals from 38 observational studies. Diabetes Care 2015; 38(9): 1804-12.
[http://dx.doi.org/10.2337/dc15-0710] [PMID: 26294775]
[67]
Buczkowska OE, Machnica Ł. Obesity and overweight in children and adolescents as a risk factor of glucose homeostasis disturbances and their complications. Clin Diabetes 2011; 12(5): 180-7.
[68]
Zhao J. Association between daily alcohol intake and risk of all-cause mortality. JAMA Netw Open 2023; 6(3): e236185.
[69]
Richelsen B, Tonstad S, Rossner S, et al. Effect of orlistat on weight regain and cardiovascular risk factors following a very-low-energy diet in abdominally obese patients: A 3-year randomized, placebo-controlled study. Diabetes Care 2007; 30(1): 27-32.
[70]
Van Gaal LF, Scheen AJ, Rissanen AM, Rössner S, Hanotin C, Ziegler O. Long-term effect of CB1 blockade with rimonabant on cardiometabolic risk factors: Two year results from the RIO-Europe Study. Eur Heart J 2008; 29(14): 1761-71.
[http://dx.doi.org/10.1093/eurheartj/ehn076] [PMID: 18417461]
[71]
Nilsson PM. Is weight loss beneficial for reduction of morbidity and mortality? What is the controversy about? Diabetes Care 2008; 31(S2): S278-83.
[http://dx.doi.org/10.2337/dc08-s268] [PMID: 18227497]
[72]
Buchwald H, Estok R, Fahrbach K, et al. Weight and type 2 diabetes after bariatric surgery: Systematic review and meta-analysis. Am J Med 2009; 122(3): 248-256.e5.
[http://dx.doi.org/10.1016/j.amjmed.2008.09.041] [PMID: 19272486]
[73]
Colquitt JL, Picot J, Loveman E, Clegg AJ. Surgery for obesity. Cochrane Database Syst Rev 2009; (2): CD003641.
[PMID: 19370590]
[74]
Garber AJ. Hypertension and lipid management in prediabetic states. J Clin Hypertens 2011; 13(4): 270-4.
[http://dx.doi.org/10.1111/j.1751-7176.2011.00451.x] [PMID: 21466625]
[75]
Diabetes Prevention Program (DPP) Research Group. The Diabetes Prevention Program (DPP): Description of lifestyle intervention. Diabetes Care 2002; 25(12): 2165-71.
[http://dx.doi.org/10.2337/diacare.25.12.2165] [PMID: 12453955]
[76]
Chwalba A, Buczkowska OE. Metabolic syndrome is the problem in young diabetics? Fam Med Sci 2014; 3(4): 2-7.

Rights & Permissions Print Cite
© 2025 Bentham Science Publishers | Privacy Policy